Smruti Pushalkar

Title: Smruti Pushalkar: Innovator in Pancreatic Cancer Research

Introduction

Smruti Pushalkar is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medical research, particularly in the area of pancreatic cancer treatment and diagnosis. His innovative work focuses on the modulation of microbiota to combat this challenging disease.

Latest Patents

Smruti Pushalkar holds a patent titled "Methods and compositions for treating and diagnosing pancreatic cancers." This patent relates to methods based on modulating mammalian intestinal and/or pancreatic microbiota, along with related probiotic, prebiotic, and anti-bacterial compositions. Specifically, it addresses the use of microbiome for the prevention, treatment, and diagnosis of pancreatic cancers or tumors, such as pancreatic ductal adenocarcinoma. He has 1 patent to his name.

Career Highlights

Smruti Pushalkar is affiliated with New York University, where he conducts his research and contributes to advancements in cancer treatment methodologies. His work is pivotal in exploring new avenues for addressing pancreatic cancer, a disease known for its high mortality rate.

Collaborations

Some of his notable coworkers include George Miller and Deepak Saxena, who collaborate with him in his research endeavors.

Conclusion

Smruti Pushalkar's innovative approach to pancreatic cancer treatment through microbiota modulation represents a significant advancement in medical research. His contributions are vital in the ongoing fight against this formidable disease.